|
|
||||||||||||||
|
|
|||||||||||||||
Therapeutics |
| The first 150 words of the full text of this article appear below. |
Data sources
Studies were identified by searching Medline, EMBASE/Excerpta Medica, the Cochrane Controlled Trials Register, DARE, and CINAHL from 1966 to 2000, and AMED, MANTIS, the Complementary and Alternative Medicine Citation Index, and AltHealthWatch from 19852000. Search terms used were diarrhoea, gastroenteritis, or rotavirus combined with competitive inhibition, Lactobacillus, probiotic, yogurt, or yoghurt. Bibliographies of relevant papers were scanned, and key investigators were contacted.
Study selection
Randomised controlled trials (RCTs) were selected if they involved Lactobacillus treatment of ID in children, clinical outcomes were reported, the treatment group received Lactobacillus and the control group received a suitable placebo, the Lactobacillus and control groups were indistinguishable, and data assessors were blinded to participant treatment group. Studies in which patients had recently received antibiotics were excluded.
Data extraction
Data were extracted on study and participant characteristics, strain of Lactobacillus, definition of diarrhoea, infectious pathogens, adverse effects, and such outcomes as duration and frequency of diarrhoea.
Main results
26
Matti Uhari, MD PhD
University of Oulu
Oulu, Finland
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |